Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE "HPS2-THRIVE"

Completed

Phase 3 Results

Main Contacts

Name Phone E-mail
Jane Armitage Principal Investigator
Colin Baigent Principal Investigator
Zhengming Chen Principal Investigator
Martin Landray Principal Investigator

Other Locations

Name City State Country Status
Clinical Trial Service Unit, University of Oxford Oxford United Kingdom Unknown_status_icon